Cerus Corporation (CERS)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $400.88M
Last updated: Nov 17, 2026 at 11:04 AM ET
Cerus Corporation (CERS) Stock Forecast
Analysts expect Cerus (CERS) to earn -$0.02 per share in the fiscal year ending Dec 31, 2026, on revenue of $242.68M. Of 4 analysts, 4 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 2 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 4 ratings average 2.00, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 0 | 0.0% |
| Buy | 4 | 100.0% |
| Hold | 0 | 0.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 4
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus turns from a loss to a profit and revenue estimates rise 9.0%.
- Fiscal year ending Dec 31, 2026
- -$0.02
- EPS consensus, revenue $242.68M
- Fiscal year ending Dec 31, 2027
- $0.02
- EPS consensus, revenue $264.41M
- Next report
- Mar 1, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.02 | -$0.02 to -$0.02 | 2 | $242.68M | $229.20M to $256.00M | 4 |
| Dec 31, 2027 | $0.02 | $0.01 to $0.02 | 2 | $264.41M | $248.44M to $278.60M | 4 |
Quarterly Estimates
The EPS consensus is -$0.01 for both quarters below, ending Dec 31, 2026 and Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.01 | -$0.01 to $0.00 | 6 | $67.55M | $59.19M to $72.45M | 6 |
| Mar 31, 2027 | -$0.01 | -$0.01 to -$0.01 | 1 | $62.70M | $58.29M to $66.40M | 3 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 0 upward and 3 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 2 |
| Fiscal year ending Dec 31, 2027 | 0 | 1 |
| Quarter ending Mar 31, 2027 | 0 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$0.04.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$0.02 | -$0.05 | -$0.05 | -$0.05 | -$0.04 | N/A |
| Fiscal year ending Dec 31, 2027 | $0.02 | -$0.01 | -$0.01 | -$0.01 | N/A | N/A |
Frequently Asked Questions About CERS
What is the CERS stock forecast?
Consensus analyst estimates put Cerus's EPS at -$0.02 for the fiscal year ending Dec 31, 2026, on revenue of $242.68M. The consensus rating from 4 analysts is Buy.
How do analysts rate CERS stock?
Of 4 analysts covering Cerus, 0 rate it Strong Buy, 4 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from CERS next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.02, with estimates from -$0.02 to -$0.02 from 2 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $0.02, with estimates from $0.01 to $0.02 from 2 analysts.
What revenue do analysts expect from Cerus next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $242.68M, with estimates from $229.20M to $256.00M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $264.41M, with estimates from $248.44M to $278.60M.
How many analysts cover CERS?
4 analysts rate Cerus stock, and 2 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
CERS pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts